SUZANO/WOODSPIN
10.5.2024 11:01:28 CEST | Business Wire | Press release
Woodspin, the exclusive producer and distributor of wood-based SPINNOVA® fibre, has obtained Forest Stewardship Council® (FSC) Chain of Custody certification. This recognizes that wood used by Woodspin for its manufacturing can be fully traced from its origin to the final fibre product, providing its customers with the assurance of sustainable sourcing.
Woodspin is a 50/50 joint venture between Suzano, the world’s largest hardwood pulp producer, and Spinnova, an innovative Finnish materials technology company. Woodspin uses responsibly grown eucalyptus hardwood planted, harvested, and sourced by Suzano on farms in Brazil. Suzano is the world’s largest eucalyptus grower and manages 26,000 km2 of land, of which 40 percent is set aside for permanent conservation.
FSC® is renowned as the most rigorous international standard for responsible forestry. FSC® certification ensures that a forest is being managed in a way that preserves biological diversity and benefits the lives of local people and workers while ensuring it sustains economic viability.
Woodspin produces the unique, wood-based SPINNOVA® fibre without harmful chemicals or pollution. SPINNOVA® fibre has a 74 percent smaller life cycle carbon footprint and 98 percent less water consumption than conventional cotton.* The exclusive use of Suzano’s eucalyptus-based raw materials enables Woodspin to guarantee end-to-end traceability while remaining committed to zero deforestation and upholding comprehensive ethical and sustainable practices.
Jari Aittakari, Sales Director at Woodspin, said:
“Consumers and stakeholders at every stage of the textiles value chain deserve to know the origin of the products they buy, that these have been ethically produced, and that the materials used to make them have been sustainably sourced.
We recognize that the demand for supply chain transparency is increasing. This FSC® certification demonstrates to our partners – be that brands or producers – that Woodspin’s SPINNOVA® fibre is produced to the highest standard, from farm to fibre, without compromise.”
Fabian Farkas, Chief Markets Officer at FSC® International, said:
“As the forestry sector continues to push boundaries through innovation, key players are increasingly recognizing FSC® as the solution provider for responsible sourcing. Woodspin's FSC® Chain of Custody certification is such a significant milestone, paving the way for a more sustainable and scalable textile fibre production and ultimately a fossil fuel-free world.”
This certification follows the 2023 opening of Woodspin’s first facility producing wood-based SPINNOVA® fibre in Jyväskylä, Finland. This plant produces biodegradable textile fibres, enabling garments with hand feel close to the natural fibres made responsively from trees. Woodspin’s modern facility uses Spinnova’s fibre technology, which is designed to produce zero waste. It uses an advanced energy recovery system to recycle its only by-product – surplus heat – which can be reused in a local heating network.
The wood-based SPINNOVA® fibre is already being used by global fashion brands such as adidas and Bestseller.
About Woodspin
Woodspin is the exclusive producer and seller of wood-based SPINNOVA® fibre, a sustainable, recyclable, material made from trees. Woodspin is a 50/50 joint venture between the world’s largest hardwood pulp producer, Suzano, and Spinnova, an innovative Finnish materials technology company. Woodspin’s unique product fuses the responsibly-grown eucalyptus hardwood of Suzano with the pioneering technology of Spinnova. In our process we use radically less water and fewer CO2 emissions than alternative fibres, requiring no harmful chemicals, and leaving no waste by-products. http://woodspin.com/
About FSC ®
FSC® is a non-profit organization that provides a proven sustainable forest management solution. Currently, over 150 million hectares of forest worldwide is certified according to FSC® standards. It is widely regarded as the most rigorous forest certification system among NGOs, consumers, and businesses alike to tackle today’s deforestation, climate, and biodiversity challenges. The FSC® forest management standard is based on ten core principles designed to address a broad range of environmental, social and economic factors. FSC’s “check tree” label is found on millions of forest-based products and verifies that they are sustainably sourced, from forest to consumer. www.fsc.org.
About SPINNOVA – Sustainable textile materials, naturally
Spinnova transforms the way textiles are manufactured globally. Based in Finland, Spinnova has developed breakthrough patented technology for making textile fibre out of wood or waste, such as leather, textile or agricultural waste, without harmful chemicals. The SPINNOVA® fibre creates zero waste, and its CO2 emissions and water consumption are minimal. SPINNOVA® fibre is biodegradable and recyclable.
Spinnova is committed to using only sustainable raw materials such as FSC certified wood and waste. SPINNOVA® fibre is produced without harmful or complex chemical processes, and has the touch and feel of natural fibres such as cotton and linen. Spinnova has received awards from Fast Company, ISPO, Scandinavian Outdoor, ANDAM, Monocle and Marie Claire UK.
Spinnova’s shares (SPINN) are listed on the Nasdaq First North Growth Market Finland.
SPINNOVA® home: www.spinnova.com
Corporate & IR site: www.spinnovagroup.com
About Suzano
Suzano is the world’s largest producer of market pulp. Our responsibly grown raw materials are used in products reaching over two billion people in more than 100 countries, including tissue and toilet paper, books, printing and writing paper, diapers and period products, packaging, textiles, and a range of innovative applications that can replace products made from fossil fuels.
Our pulp is made using biomass produced from farmed eucalyptus trees, offering a biodegradable, renewable and recyclable raw material for consumer and industrial use. We plant 1.2 million trees a day and only harvest what we plant. We manage around 26,000 km2 of land and around 40% of this is protected for permanent conservation, with a zero deforestation policy across all of our operations.
Suzano’s history goes back over 100 years. We are listed on the B3 stock exchange in Brazil (SUZB3) and the NYSE (SUZ) in the United States. Learn more at: www.suzano.com.br/en.
Disclaimer
*CO2e emission comparison is based on a projected product carbon footprint conducted by a third-party expert following the ISO 14067:2018 standard. Ecoinvent database has been used as the source for global average CO2e emissions of conventional cotton. Water consumption comparison is based on a projected, screening Life Cycle Assessment (LCA) conducted by a third-party expert. Both comparisons include raw material supply, transportation of raw materials, and manufacturing of the product (cradle-to-gate).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240510834910/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Real Chemistry Announces New Asia Pacific Hub with Acquisition of Spurwing Communications in Singapore7.7.2026 01:00:00 CEST | Press release
Expanded footprint advances the company’s global strategy in key growth region for healthcare and pharma brands Real Chemistry, a global leader in AI- and insights-driven healthcare communications, today announced the acquisition of Spurwing Communications, establishing the company’s first Asia Pacific (APAC) strategic hub in Singapore. This milestone strengthens Real Chemistry’s global strategy and presence in APAC, enhancing its ability to support healthcare organizations. Combining deep market expertise with globally integrated capabilities across analytics, medical communications, advertising and strategic communications, the company is well positioned to deliver more connected, local insight-driven support — ultimately helping clients better reach and engage healthcare professionals, patients and caregivers across the region. “APAC is fast becoming one of the most dynamic and strategically important regions for healthcare innovation and access to life-improving therapies,” said Ka
Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 22:04:00 CEST | Press release
- Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex’s portfolio - - PALSONIFY®, Crinetics’ recently launched, first and only, once-daily oral therapy for adults with acromegaly has demonstrated strong and growing early uptake - - Atumelnant, a once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist in Phase 3 development for congenital adrenal hyperplasia (CAH), has shown unique and transformative potential to both normalize androgen levels and enable management of patients with physiologic levels of glucocorticoids, the true goal of CAH management; atumelnant has also demonstrated therapeutic potential in patients with Cushing’s syndrome - - Acquisition adds to Vertex’s innovation pipeline, accelerates Vertex’s revenue growth and enhances long-term earnings profile - - Vertex to host investor call today, July 6 at 4:30 p.m. ET - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and C
Ciauru Wins the Second Edition of the Reply AI Music Contest, the International Competition Dedicated to Experimentation Across AI, Music and Live Performance6.7.2026 20:30:00 CEST | Press release
The winner was announced on the Kappa FuturFestival stage, following the performances of the five finalists selected by the international jury.German duo PARAFRAME & Avis Vox received the special Reply AI Studios Grand Prix award. The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706007611/en/ The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival First place went to Ciauru, the stag
Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 20266.7.2026 15:00:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced it will report earnings after market close on July 30, 2026. The company will host a conference call and webcast on that date to discuss the second quarter 2026 results and the second half 2026 outlook at 5:00 p.m. Eastern / 2:00 p.m. Pacific time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706560476/en/ Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 2026 A live webcast of the event will be available on Rimini Street’s Investor Relations site via the Rimini Street IR events link and directly via the webcast link. Dial-in participants can access the conference by dialing 1-800-836-8184. A replay of the webcast will be available for one year following the event. About Rimini Street, Inc. Rimini Street, Inc. (Nasda
Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe6.7.2026 15:00:00 CEST | Press release
Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for intravenous (IV) nivolumab biosimilar referencing one of the world’s most widely used cancer immunotherapies to widen patient access across Europe. Nivolumab helped usher in the era of immuno-oncology, transforming the outlook for patients with cancers such as melanoma and lung cancer. As the originator approaches loss of exclusivity in Europe, this partnership aims to put a high-quality, EU-GMP-manufactured nivolumab biosimilar within reach of more patients, reducing healthcare burden. In 2025, Nivolumab recorded sales of approximately USD4.1 billion (Source: IQVIA/IMS) Europe — underscoring the scale of the opportunity. Under the agreement, Orion will hold the exclusive rights to register, market, distribute and sell the nivolumab biosimilar across Europe. Shilpa Biologicals will lead product developm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
